Yanming Dong

673 total citations
36 papers, 466 citations indexed

About

Yanming Dong is a scholar working on Infectious Diseases, Molecular Biology and Dermatology. According to data from OpenAlex, Yanming Dong has authored 36 papers receiving a total of 466 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Infectious Diseases, 10 papers in Molecular Biology and 6 papers in Dermatology. Recurrent topics in Yanming Dong's work include Parvovirus B19 Infection Studies (9 papers), Virus-based gene therapy research (5 papers) and Breast Cancer Treatment Studies (4 papers). Yanming Dong is often cited by papers focused on Parvovirus B19 Infection Studies (9 papers), Virus-based gene therapy research (5 papers) and Breast Cancer Treatment Studies (4 papers). Yanming Dong collaborates with scholars based in China, United States and France. Yanming Dong's co-authors include David J. Pintel, Lixin Ma, Jingwen Luo, Zhenzhong Guo, Ping Yang, Zhiwei Zhang, Yunhong Hu, Shiwei Chen, Nicole Jaffrézic‐Renault and N. Jaffrezic-Renault and has published in prestigious journals such as PLoS ONE, Journal of Virology and Carbohydrate Polymers.

In The Last Decade

Yanming Dong

33 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanming Dong China 15 186 92 82 76 71 36 466
Sergei Pustylnikov United States 8 270 1.5× 66 0.7× 56 0.7× 55 0.7× 154 2.2× 12 490
Hsiung‐Fei Chien Taiwan 15 138 0.7× 35 0.4× 59 0.7× 35 0.5× 46 0.6× 27 618
Amal Seffouh Canada 15 431 2.3× 50 0.5× 63 0.8× 48 0.6× 48 0.7× 20 691
Husain Attarwala United States 11 458 2.5× 90 1.0× 48 0.6× 56 0.7× 117 1.6× 19 760
Dickson Adah China 15 288 1.5× 43 0.5× 73 0.9× 92 1.2× 154 2.2× 22 714
Fu‐Fei Hsu Taiwan 11 316 1.7× 87 0.9× 47 0.6× 57 0.8× 113 1.6× 15 636
Anders B. Dohlman United States 9 372 2.0× 49 0.5× 59 0.7× 66 0.9× 182 2.6× 13 660
Jonathan T. Sims United States 15 263 1.4× 137 1.5× 47 0.6× 44 0.6× 133 1.9× 29 741
Zheng Wu China 12 117 0.6× 56 0.6× 73 0.9× 22 0.3× 28 0.4× 20 391

Countries citing papers authored by Yanming Dong

Since Specialization
Citations

This map shows the geographic impact of Yanming Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanming Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanming Dong more than expected).

Fields of papers citing papers by Yanming Dong

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanming Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanming Dong. The network helps show where Yanming Dong may publish in the future.

Co-authorship network of co-authors of Yanming Dong

This figure shows the co-authorship network connecting the top 25 collaborators of Yanming Dong. A scholar is included among the top collaborators of Yanming Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanming Dong. Yanming Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Xiaopeng, Shiming Zhou, Jingyi Zeng, et al.. (2024). A biodegradable lipid nanoparticle delivers a Cas9 ribonucleoprotein for efficient and safe in situ genome editing in melanoma. Acta Biomaterialia. 190. 531–547. 8 indexed citations
2.
Dong, Yanming, et al.. (2024). Opportunities and challenges of microneedle electrochemical sensors for interstitial fluid detection. TrAC Trends in Analytical Chemistry. 180. 117891–117891. 33 indexed citations
3.
Yang, Xiaopeng, Le Chang, Qian Lin, et al.. (2024). Microneedle pretreatment and cationic nanoparticles for transdermal delivery of doxorubicin against melanoma. Journal of Drug Delivery Science and Technology. 93. 105417–105417. 2 indexed citations
4.
Yang, Xuan, Yue Wang, Chengming Xu, et al.. (2024). MIRA/PfAgo-Mediated Biosensor for Multiplex Human Enteroviruses Virus Typing Detection on HFMD. ACS Synthetic Biology. 13(12). 4119–4130. 2 indexed citations
5.
Chen, Yuhao, Xuan Yang, Weiran Chen, et al.. (2024). PfAgo-Based Zika Virus Detection. Viruses. 16(4). 539–539. 5 indexed citations
6.
Wang, Yue, Yun Zeng, Nicole Jaffrézic‐Renault, et al.. (2024). A DNA sensor based on CbAgo effector protein and on a dual electrochemical signal amplification strategy for B19 parvovirus detection. Bioelectrochemistry. 162. 108860–108860. 5 indexed citations
7.
Zhou, Qiaoqiao, Lei Zhang, Yanming Dong, et al.. (2023). The role of SARS-CoV-2-mediated NF-κB activation in COVID-19 patients. Hypertension Research. 47(2). 375–384. 25 indexed citations
8.
Chen, Weiran, Ting Luo, Xueying Wang, et al.. (2023). Novel Nucleic Acid Detection for Human Parvovirus B19 Based on Pyrococcus furiosus Argonaute Protein. Viruses. 15(3). 595–595. 17 indexed citations
9.
Yang, Ping, Zhenyu Yang, Yanming Dong, et al.. (2023). Clusterin is a biomarker of breast cancer prognosis and correlated with immune microenvironment. Translational Cancer Research. 12(1). 31–45. 14 indexed citations
10.
Yang, Ping, Gang Wei, Lijuan Yuan, et al.. (2023). Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low. Breast Cancer Research. 25(1). 34–34. 27 indexed citations
12.
Cheng, Yibin, Caixia Wang, Huihui Wang, et al.. (2022). Combination of an autophagy inhibitor with immunoadjuvants and an anti-PD-L1 antibody in multifunctional nanoparticles for enhanced breast cancer immunotherapy. BMC Medicine. 20(1). 411–411. 31 indexed citations
13.
14.
Dong, Yanming, et al.. (2021). The application of the three-dimensional high-definition laparoscope in thyroid microcarcinoma. Translational Cancer Research. 10(2). 977–982.
15.
Hu, Yunhong, Yang Wang, Fei Wang, et al.. (2020). SPOP negatively regulates Toll-like receptor-induced inflammation by disrupting MyD88 self-association. Cellular and Molecular Immunology. 18(7). 1708–1717. 35 indexed citations
16.
Dong, Yanming, et al.. (2018). MARCH5 overexpression contributes to tumor growth and metastasis and associates with poor survival in breast cancer. Cancer Management and Research. Volume 11. 201–215. 24 indexed citations
17.
Deng, Xuefeng, Yanming Dong, Dan Zhao, et al.. (2013). The Determinants for the Enzyme Activity of Human Parvovirus B19 Phospholipase A2 (PLA2) and Its Influence on Cultured Cells. PLoS ONE. 8(4). e61440–e61440. 19 indexed citations
18.
Li, Yasha, et al.. (2012). High prevelance of human parvovirus infection in patients with malignant tumors. Oncology Letters. 3(3). 635–640. 15 indexed citations
19.
Dong, Yanming, et al.. (2010). Cloning and expression of nonstructural protein genes ns1 and 7.5 ku of Human parvovirus B19.. Journal of Pathogen Biology. 5(7). 481–484. 1 indexed citations
20.
Xie, Rong, et al.. (2010). Linearization variance estimation for generalized raking estimators in the presence of nonresponse. RePEc: Research Papers in Economics. 100(4). 265–269. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026